Unknown

Dataset Information

0

Microbial therapeutics: New opportunities for drug delivery.


ABSTRACT: With >40 clinical trials underway, we are nearing the first FDA-approved live microbial therapeutic. Here, Giovanni Traverso, MIT and Harvard Medical School Assistant Professor, and colleagues Miguel Jimenez and Institute Professor Robert Langer from MIT discuss the significant challenges of administering live microorganisms to patients and the opportunities for drug delivery of these new complex therapeutics.

SUBMITTER: Jimenez M 

PROVIDER: S-EPMC6504217 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7601382 | biostudies-literature
| S-EPMC8033518 | biostudies-literature
| S-EPMC8178217 | biostudies-literature
| S-EPMC4742986 | biostudies-other
| S-EPMC5565796 | biostudies-other
| S-EPMC8231102 | biostudies-literature
| S-EPMC7339658 | biostudies-literature
| S-EPMC5503194 | biostudies-literature
| S-EPMC7313641 | biostudies-literature
| S-EPMC6968566 | biostudies-literature